Trial Profile
Effects of GnRH and Raloxifen on the size of uterine lyomioma
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Gonadotropin releasing hormone
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 04 Jul 2014 New trial record
- 05 May 2013 Iranian Registry of Clinical Trials reports recruitment completed.